RxDoctor Payments Data

Thomas Waller, MD

Family Medicine · Jacksonville, FLNPI 1629066857

Payments from drug & device makers

$1,685in general payments, 2019–2025

Across 23 payments — averaging $73.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$660
  • Pfizer$250
  • E.r. Squibb & Sons, L.L.C.$219
  • AbbVie$207
  • Dexcom, Inc.$90
  • AstraZeneca$87
  • plus $172 from 3 others

What the payments were for

  • Travel & lodging$493%
  • Food & beverage$1,63697%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,685 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$122,967
Medicare patients
602
Services billed
1,503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$55,680
XareltoRivaroxaban12$16,986
OzempicSemaglutide11$11,088
JardianceEmpagliflozin19$10,635
Atorvastatin Calcium209$2,321
SynthroidLevothyroxine Sodium16$2,242
Rosuvastatin Calcium59$1,464
Losartan Potassium92$976
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide36$859
Amlodipine Besylate122$810
Levothyroxine Sodium55$795
Ipratropium Bromide13$709
Tamsulosin Hcl20$606
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$594
Alprazolam19$562

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$250$55,68040 claims
Novo NordiskOzempic$660$11,08811 claims
AbbVieSynthroid$207$2,24216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →